Home » Newsletters » BioWorld

BioWorld

Dec. 7, 2001

View Archived Issues

Millennium Buying COR, Integrilin In Stock Deal Valued At $2 Billion

ODAC Recommends Approval Of Guilfords Brain Cancer Product

Enzymes Belly-Fat Buildup Threatens Chain Of Diseases Seen In Metabolic Syndrome

Cephalon, Invitrogen Each Places $500 Million Of Convertible Notes

Other News To Note